India’s cough syrup crackdown — what prompted it and what follows, Pg22

• Government restricted use of a cold drug combination (FDC) in children under 4 years.
• Drugs involved: Chlorpheniramine maleate (antihistamine) + Phenylephrine hydrochloride (decongestant).
• Advisory issued by Ministry of Health and Family Welfare (April 15) post review by Subject Expert Committee.
• Pharmacists and doctors raise concerns over prescriptions, stock clarity, and availability of safer alternatives.

Detailed Insights:

1. What is the FDC in question?

• Chlorpheniramine: First-generation sedative antihistamine for allergy symptoms.
• Phenylephrine: Nasal decongestant that shrinks blood vessels in the nose.
• This combo is widely sold in OTC cough syrups for kids.
  2. Why the crackdown?
• Studies and paediatric evidence showed:
• High risk of side effects (especially sedation, arrhythmias).
• No proven benefit in reducing cold duration in children.
• Safer, newer second-generation antihistamines exist (e.g., cetirizine, fexofenadine).
• International norms already discouraged use of these in young children.
  3. Implications for Pharmacies & Doctors:
• FDCs still available as existing stocks remain in circulation.
• Pharmacists are unclear whether to honour prescriptions already issued.
• Doctors advised to prescribe newer, safer molecules and explain clearly to parents.
  4. Manufacturer Liability & Regulatory Gap:
• Govt asked manufacturers to:
• Label warnings clearly.
• Remove such combinations from promotional literature.
• State drug authorities are responsible for pulling stocks from shelves.
• High Court of Delhi allowed continued sale of existing stock pending final judgment.
  Scientific/Technical Concepts Involved:
• Fixed Dose Combination (FDC): Two or more drugs combined in a fixed ratio in a single dosage form.
• First vs Second Generation Antihistamines:
• 1st-gen: Cause sedation (cross blood-brain barrier).
• 2nd-gen: Safer for children; do not cause drowsiness.
• Pharmacovigilance: Post-market surveillance of drug safety.
  Significance:
• Reflects growing regulatory action in public health protection, especially for children.
• Pushes Indian pharmaceutical regulation closer to global safety standards.
• Emphasises the importance of rational drug prescription and patient education.

Mains Mock Question:

Discuss the rationale behind India’s recent restriction on certain fixed-dose cough syrup combinations for children. What does this signify for public health regulation and drug safety in India?